Sign in

CIK 0000014272 · Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
220790350
Phone
6092524621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Massacesi Cristian −$403K EVP,Chief Med Offr,Head of Dev sold 25% of stake
  2. Haller Julia A −$241K Director sold 11% of stake
  3. Holzer Phil M −$34K SVP and Controller sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other disposition −337 68,481.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −2,327 $63.11 $147K 66,154.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise +4,765 70,919.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other disposition −831 70,088.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −2,013 $63.11 $127K 68,075.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise +5,854 73,929.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other disposition −998 72,931.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −2,484 $63.11 $157K 70,447.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise +28,593 99,040.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Other disposition −10,545 88,495.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Shares withheld for taxes −9,232 $63.11 $583K 79,263.49
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise · Market Share Units −4,886 0
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise · Market Share Units −4,765 4,767
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise · Market Share Units −5,854 11,711
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Grant or award · Market Share Units +35,146 35,146
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Option exercise · Performance Shares −28,593 0
2025-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Grant or award · Performance Shares +52,720 52,720
2025-03-10 Hickey Benjamin President, RayzeBio Org. Grant or award · Market Share Units +13,389 13,389
2025-03-10 Hickey Benjamin President, RayzeBio Org. Grant or award · Performance Shares +20,084 20,084
2025-03-10 Gallman Cari EVP, Corporate Affairs Option exercise +349 5,368

Page 23 of 40 · 799 trades